Eli Lilly and Receives Neutral Rating from Zacks

Home › Eli Lilly and Receives Neutral Rating from Zacks

's stock had its "neutral" rating restated by Zacks in a report released on Friday.

24.09	Hurricane John Graphics
24.09	Hurricane John Public Advisory Number 6A
24.09	Potential Tropical Cyclone Nine Public Advisory Number 2A
24.09	Summary for Potential Tropical Cyclone Nine (AT4/AL092024)
24.09	CrowdStrike: Company to face questions over global IT outage
24.09	Tigers and crocs make mangrove preservation tough work
24.09	Atlantic Tropical Weather Outlook
24.09	Eastern North Pacific Tropical Weather Outlook
More »

je.st